Clinical Trial Update: Nebulized Heparin for the Treatment of COVID-19 [Phase 4]

View source ↗

Summary

Phase 4 trial update investigating nebulized heparin for the treatment of COVID-19, with completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• Nebulized Heparin (unfractionated heparin)

Snippet

Sponsor: Frederick Health | Conditions: Covid19, Pneumonia, Viral | Phase 4 | Status: COMPLETED